The company will carry out a reverse stock split in a ratio of 1:100. The share will be traded under new ISIN code with effect from Dec 1, 2025. The order book will not change.
| Short name: | BIOSGN |
| Terms: | Reverse split: 1:100 |
| Current ISIN: | SE0016013460 |
| Last day of trading with current ISIN code: | Nov 28, 2025 |
| New ISIN code: | SE0026821852 |
| First day of trading with new ISIN code: | Dec 1, 2025 |
Nasdaq Stockholm AB, Issuer Surveillance, dl-ilasto@nasdaq.com, +46 8 405 7280
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 10.02. | Biosergen AB: Biosergen publishes interim report for the fourth quarter 2025 | February 10, 2026: Biosergen AB ("Biosergen" or the "Company") hereby publishes the interim report for the fourth quarter 2025. The interim report is available as an attached document and on the company... ► Artikel lesen | |
| 01.12.25 | XFRA NEW INSTRUMENTS AVAILABLE ON 01.12.2025 | The following instruments on XETRA do have their first trading 01.12.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 01.12.2025
Aktien
1 IT0005678104 Kaleon S.p.A.
2 IM00BYYPQX37... ► Artikel lesen | |
| 28.11.25 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.11.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 28.11.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.11.2025ISIN NameCA38940L2057 GRAYCLIFF... ► Artikel lesen | |
| 28.11.25 | XFRA ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA60283T2074 Mineral Hill Industries Ltd. 28.11.2025 CA38077F1045 Gold Strategy Inc. 01.12.2025 Tausch 1:1US60855D3098 Moleculin... ► Artikel lesen | |
| 28.11.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 28.11.2025 | Das Instrument 8N1 SE0016013460 BIOSERGEN AB EQUITY wird cum Kapitalmassnahme gehandelt am 28.11.2025 und ex Kapitalmassnahme am 01.12.2025 The instrument 8N1 SE0016013460 BIOSERGEN AB EQUITY is traded... ► Artikel lesen |
